Table 1: FDA-approved HDAC inhibitors.
Inhibitor influence on Class I HDAC activity is described in the provided references.
| Inhibitor | Alternative Names | References |
|---|---|---|
| Vorinostat | Zolinza Suberoylanilide Hydroxamic Acid (SAHA) |
Richon et al., 1998, Khan et al., 2008, Bantscheff et al., 2011 |
| Romidepsin | Istodax Chromadax FK228 |
Furumai et al., 2002, Bantscheff et al., 2011 |
| Belinostat | Beleodaq PXD101 |
Khan et al., 2008, Bantscheff et al., 2011 |
| Panobinostat | Farydak LBH589 |
Khan et al., 2008, Bantscheff et al., 2011 |